Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.190
-0.054 (-22.13%)
At close: Nov 22, 2024, 4:00 PM
0.179
-0.012 (-6.05%)
After-hours: Nov 22, 2024, 7:58 PM EST
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of $3.77 million as of November 22, 2024. Its market cap has decreased by -81.06% in one year.
Market Cap
3.77M
Enterprise Value
6.43M
1-Year Change
-81.06%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since May 31, 2002, Aptose Biosciences's market cap has decreased from $67.90M to $3.77M, a decrease of -94.45%. That is a compound annual growth rate of -12.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 5.30M | -73.37% |
Dec 29, 2023 | 19.90M | -62.80% |
Dec 30, 2022 | 53.50M | -55.45% |
Dec 31, 2021 | 120.10M | -69.14% |
Dec 31, 2020 | 389.20M | 23.71% |
Dec 31, 2019 | 314.60M | 499.24% |
Dec 31, 2018 | 52.50M | 49.15% |
Dec 29, 2017 | 35.20M | 110.78% |
Dec 30, 2016 | 16.70M | -43.58% |
Dec 31, 2015 | 29.60M | -52.10% |
Dec 31, 2014 | 61.80M | 461.82% |
Dec 31, 2013 | 11.00M | 71.88% |
Dec 31, 2012 | 6.40M | 255.56% |
Dec 30, 2011 | 1.80M | -79.31% |
Dec 31, 2010 | 8.70M | -33.59% |
Dec 31, 2009 | 13.10M | 104.69% |
Dec 31, 2008 | 6.40M | -79.62% |
Dec 31, 2007 | 31.40M | -18.23% |
Dec 29, 2006 | 38.40M | -10.90% |
Dec 30, 2005 | 43.10M | -58.20% |
Dec 31, 2004 | 103.10M | -6.10% |
Dec 31, 2003 | 109.80M | 130.19% |
Dec 31, 2002 | 47.70M | -29.75% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aptevo Therapeutics | 5.03M |
Bionomics | 5.01M |
Purple Biotech | 4.82M |
Sunshine Biopharma | 4.78M |
Biofrontera | 4.77M |
Predictive Oncology | 4.72M |
Check-Cap | 4.68M |
Silexion Therapeutics | 4.58M |